Total Payments
$13,170
2024 Payments
$2,551
Companies
61
Transactions
770
Medicare Patients
614
Medicare Billing
$60,335
Payment Breakdown by Category
Food & Beverage$13,147 (99.8%)
Education$23.05 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,147 | 767 | 99.8% |
| Education | $23.05 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,259 | 116 | $0 (2024) |
| Novo Nordisk Inc | $934.35 | 49 | $0 (2024) |
| ABBVIE INC. | $928.27 | 45 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $913.65 | 58 | $0 (2024) |
| Amgen Inc. | $896.70 | 47 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $890.16 | 53 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $561.45 | 27 | $0 (2021) |
| GlaxoSmithKline, LLC. | $506.78 | 32 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $462.65 | 20 | $0 (2024) |
| Allergan, Inc. | $455.48 | 25 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,551 | 125 | Phathom Pharmaceuticals, Inc. ($462.65) |
| 2023 | $860.09 | 41 | ABBVIE INC. ($170.30) |
| 2022 | $1,785 | 83 | ABBVIE INC. ($304.58) |
| 2021 | $672.47 | 35 | AbbVie Inc. ($149.01) |
| 2020 | $657.45 | 47 | PFIZER INC. ($127.90) |
| 2019 | $2,069 | 143 | PFIZER INC. ($286.22) |
| 2018 | $2,520 | 157 | Amgen Inc. ($399.76) |
| 2017 | $2,056 | 139 | Supernus Pharmaceuticals, Inc. ($326.86) |
All Payment Transactions
770 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: NEUROLOGY | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.17 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Central Nervous System | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.58 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: NEUROLOGY | ||||||
| 11/23/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $43.49 | General |
| Category: OUD | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Diabetes Care | ||||||
| 11/19/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: OUD | ||||||
| 11/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: VACCINES | ||||||
| 11/18/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $3.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 130 | 151 | $33,695 | $12,236 |
| 2022 | 4 | 144 | 176 | $44,934 | $16,045 |
| 2021 | 3 | 125 | 144 | $23,200 | $14,682 |
| 2020 | 6 | 215 | 329 | $42,055 | $17,372 |
Total Patients
614
Total Services
800
Medicare Billing
$60,335
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 78 | $20,736 | $6,990 | 33.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 21 | 21 | $5,158 | $2,757 | 53.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,608 | $1,403 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 14 | $2,609 | $909.40 | 34.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $428.00 | $129.78 | 30.3% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 13 | 13 | $156.00 | $46.20 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 95 | $27,740 | $8,917 | 32.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 37 | 37 | $11,026 | $4,970 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 28 | $5,768 | $2,015 | 34.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 14 | 16 | $400.00 | $143.07 | 35.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 43 | 43 | $6,880 | $5,931 | 86.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 60 | $11,400 | $5,706 | 50.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 41 | $4,920 | $3,045 | 61.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 87 | 196 | $31,556 | $12,195 | 38.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 32 | 32 | $5,408 | $3,868 | 71.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 24 | $2,616 | $843.64 | 32.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 38 | 38 | $1,900 | $387.84 | 20.4% |
| 81003 | Automated urinalysis test | Office | 2020 | 26 | 28 | $420.00 | $62.45 | 14.9% |
| 94760 | Measurement of oxygen saturation in blood using ear or finger device | Office | 2020 | 11 | 11 | $155.00 | $14.66 | 9.5% |
About Dr. Jonathan Martin, M.D
Dr. Jonathan Martin, M.D is a Internal Medicine healthcare provider based in East Greenwich, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2009. The National Provider Identifier (NPI) number assigned to this provider is 1528209335.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Martin, M.D has received a total of $13,170 in payments from pharmaceutical and medical device companies, with $2,551 received in 2024. These payments were reported across 770 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($13,147).
As a Medicare-enrolled provider, Martin has provided services to 614 Medicare beneficiaries, totaling 800 services with total Medicare billing of $60,335. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location East Greenwich, RI
- Active Since 03/09/2009
- Last Updated 10/30/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1528209335
Products in Payments
- XARELTO (Drug) $755.33
- UBRELVY (Drug) $675.14
- Ozempic (Drug) $498.23
- VOQUEZNA (Drug) $462.65
- CHANTIX (Drug) $440.25
- FARXIGA (Drug) $402.13
- Trintellix (Drug) $396.86
- TROKENDI XR (Drug) $381.32
- TOUJEO (Drug) $347.13
- NUEDEXTA (Drug) $342.98
- Belviq (Drug) $324.50
- ELIQUIS (Drug) $312.89
- VRAYLAR (Drug) $262.74
- NURTEC ODT (Drug) $243.34
- Prolia (Biological) $240.75
- NUZYRA (Drug) $231.15
- Aimovig (Biological) $219.95
- SYMBICORT (Drug) $212.03
- ZENPEP (Drug) $202.01
- Otezla (Drug) $178.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in East Greenwich
Dr. David Fried, Md, MD
Internal Medicine — Payments: $248,518
Internal Medicine $248,518
Dr. Todd Viccione, Md, MD
Internal Medicine — Payments: $25,434
Internal Medicine $25,434
Dr. Richard Leach, Do, DO
Internal Medicine — Payments: $6,095
Internal Medicine $6,095
Dr. Shahid Khan, Md, MD
Internal Medicine — Payments: $4,742
Internal Medicine $4,742
Leah Marano
Internal Medicine — Payments: $576.35
Internal Medicine $576.35
Silvia Pena, Md, MD
Internal Medicine — Payments: $535.25
Internal Medicine $535.25